Predictors of Discontinuation of Eribulin Therapy for Metastatic Breast Cancer: A Retrospective Cohort Study
Background/Aim: This study aimed to identify clinical predictors associated with early discontinuation of eribulin therapy in patients with unresectable or recurrent breast cancer. Patients and Methods: We retrospectively reviewed data for 63 patients with breast cancer starting eribulin therapy between August 2011 and...